Trials / Completed
CompletedNCT05550688
Weight Gain After Smoking Cessation and NAFLD
The Effect of Weight Gain After Smoking Cessation Increased the Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,941 (actual)
- Sponsor
- Ningbo No. 1 Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common chronic liver disease. Considering that there are no approved pharmacological treatments, lifestyle modification is necessary and challenging to reduce the risk of type 2 diabetes mellitus (T2DM) in patients with NAFLD. Cigarette smoking has a significant negative impact on public health, causing more than 480,000 deaths each year. Smoking has been reported as a risk factor for NAFLD and might accelerate liver disease progression. Therefore, it is recommended that patients with NAFLD quit smoking. However, smoking cessation could be complicated by weight gain. Thus, it is important to assess the impact of weight change after smoking cessation on patients with NAFLD. Proper management of post-cessation weight could maximize its health benefits. In this large-scale cohort study, the investigators aimed to assess the effects of smoking cessation and subsequent weight change on risks of incident T2DM in individuals with NAFLD.
Conditions
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2014-12-31
- Completion
- 2022-08-01
- First posted
- 2022-09-22
- Last updated
- 2022-09-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05550688. Inclusion in this directory is not an endorsement.